Chromosome abnormalities in peripheral lymphocytes from patients with progressive systemic sclerosis

Area of Science:

• Cytogenetics
• Immunology
• Rheumatology

Background:

• Progressive systemic sclerosis (PSS) is an autoimmune disease characterized by fibrosis and vascular abnormalities.
• Chromosomal aberrations have been investigated as potential biomarkers in various diseases.
• The genotoxic effects of PSS and its treatments are not fully understood.

Purpose of the Study:

• To investigate chromosomal abnormalities in peripheral lymphocytes of PSS patients.
• To compare the frequency of chromosome aberrations between treated and untreated PSS patients and healthy controls.
• To explore potential links between PSS, medical treatments, and chromosomal damage.

Main Methods:

• Cultured peripheral lymphocytes were analyzed from 14 PSS patients and 15 normal subjects.
• Standard cytogenetic techniques were employed to detect chromosome aberrations.
• Frequencies of different types of aberrations, including dicentrics, were quantified.

Main Results:

• No significant increase in chromosome aberrations was observed in PSS patients who had not received medical treatment.
• A slight increase in the frequency of dicentrics (0.3%) was noted in PSS patients who had received medication.
• This increase in dicentrics was not statistically significant when compared to normal subjects.

Conclusions:

• Medical treatment, rather than PSS itself, may be associated with a minor increase in chromosomal aberrations like dicentrics.
• The observed increase in dicentrics in treated PSS patients requires further investigation.
• The potential hypersensitivity of PSS patients to therapeutic agents warrants further study regarding genotoxic effects.